18 Nov 2019
WRD PfizerWorld Pages; Cambridge, MA
Last week, Pfizer KSQ hosted several National Institutes of Health (NIH) OxCam scholars for a tour of our R&D site and a panel discussion on discovery research and development at Pfizer and the industrial R&D career path. The scholars are working on their doctoral degrees in a collaborative program between the NIH in Bethesda, MD and Oxford and Cambridge Universities in the U.K.
Tom Wynn, Vice President, I&IRU Discovery Research and a former director of the NIH-OxCam scholars program welcomed the group and shared his unique insights on research opportunities at a large pharmaceutical company.
In addition, the scholars participated in a panel discussion to interact with and hear first-hand from several colleagues representing many of the disciplines housed at Pfizer KSQ. The panel was moderated by Matt Maciejewski, Principal Scientist, Computational Biology and an alumni of the NIH-OxCam Scholars program.
“It was a great day meeting and interacting with this group of scholars,” adds Tom. “It’s important that we host events like this to ensure that top-tier emerging talent is aware of the caliber of R&D happening at Pfizer.”
After hearing first-hand accounts of R&D at Pfizer, the scholars enjoyed a lab tour led by another NIH-OxCam alum, Trey Gieseck, Principal Scientist, I&IRU, followed by lunch with additional Pfizer colleagues. Their Cambridge visit concluded with a tour of LabCentral and discussions with a few of their resident entrepreneurs.
Thank you to Pfizer for publishing this article and hosting the NIH-OxCam scholars.